Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study

Abstract

Chinese Clinical Trial Register (ChiCTR): ChiCTR-ONC-12002689.

Innovative Blood Tests for Hepatocellular Carcinoma: Liquid Biopsy and Evaluation of Systemic Inflammatory Reaction

“…Dynamic changes of NLR had independent prognostic significance (p = 0.035) in HCC with portal vein tumour thrombosis treated by microwave ablation after transarterial chemoembolisation [60]. In 506 patients treated by thermal ablation of recurrent HCC, high pretreatment NLR (≥2.14) was a prognostic factor for recurrence-free survival, confirmed by…”

A prognostic nomogram for colorectal cancer liver metastases after percutaneous thermal ablation

“…In patients with vascular/biliary tumour thrombosis, the thrombosis was treated via thermal ablation. Specific ablation procedures for tumour thrombosis have been reported in previous papers [18,37].…”

Hepatocellular Carcinoma: Combined Transarterial Chemoembolization and Ablation

“…Combination therapy with MWA after TACE may provide a substantial benefit for patients with HCC who have portal vein thrombosis (PVTT) and Child-Pugh class A or B. 35 In one study, while MWA and RFA, when combined with neoadjuvant TAE or TACE, had similar safety and efficacy profiles in the treatment of early-stage HCC, TACE/TAE and MWA provided more durable disease control in this study when compared with TACE/TAE and RFA. 36 A separate study found that MWA plus TACE is a safe, feasible, and effective therapy in the treatment of 5 to 10 cm HCC in patients with cirrhosis.…”